Earningsreport

Q3/2024 9/30/2024 EPS -0.070 ZacksConsensus -0.070 ActVsEst 0.000 - In-Line

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com